2007
THE EXPRESSION OF THE Fc GAMMA RECEPTORS (CD16, CD32, CD64) ON LEUKOCYTES IN THE COMMON VARIABLE IMMUNODEFICIENCY (CVID)
LOKAJ, Jindřich; Vojtěch THON; Marcela VLKOVÁ; Tomáš FREIBERGER; Jiří LITZMAN et al.Základní údaje
Originální název
THE EXPRESSION OF THE Fc GAMMA RECEPTORS (CD16, CD32, CD64) ON LEUKOCYTES IN THE COMMON VARIABLE IMMUNODEFICIENCY (CVID)
Název česky
Exprese Fcgama receptorů na leukocytech pacientů s běžným variabilním imunodeficitem(CVID)
Vydání
13th International Congress of Immunology, 2007
Další údaje
Jazyk
angličtina
Typ výsledku
Prezentace na konferencích
Obor
30102 Immunology
Stát vydavatele
Brazílie
Utajení
není předmětem státního či obchodního tajemství
Označené pro přenos do RIV
Ne
Organizační jednotka
Lékařská fakulta
Klíčová slova anglicky
common variable immunodeficiency, Ig Gamma receptors, immune activation
Příznaky
Mezinárodní význam
Změněno: 27. 1. 2008 10:49, prof. MUDr. Jiří Litzman, CSc.
V originále
CVID is most frequent symptomatic primary hypogammaglobulinemia. The foundation of therapy for CVID is immunoglobulin replacement. The factors that influence the effect of this therapy are not elucidated. It should be supposed participation of receptors for immunoglobulins on professional phagocytes and lymphocytes. We have investigated 41 patients (13 males, 28 females, aged 10-77 years) and 44 age-related control persons. Quantitative expression of the Fc receptors on the surface of lymphocytes, monocytes, and granulocytes was determined by flow cytometry. Gene polymorphism of Fc receptors was determined by PCR. The expression of CD16, CD 32 and CD64 on lymphocytes and monocytes was comparable in patients and control persons, also the expression of CD16 and CD32 on granulocytes was similar in both groups. However, we have found marked differences in the expression of CD64 on granulocytes in CVID patients: in patients with high expression of CD64 on their granulocytes the clinical state and effectivity of standard treatment with intravenous immunoglobulin was significantly worse than in patients with low expression of this receptor. Our results suggest that the gravity in the clinical course of CVID patients and efficacy of immunoglobulin therapy may relate to the upregulation of Fc gamma receptor I (CD64) on granulocytes.
Česky
Sledován výsky exprese Fc gama receptorů na povrchu leukocytů nemocných s běžným variabilním imunodeficitem.
Návaznosti
| NR9035, projekt VaV |
|